Synapse

← The Lancet Regional Health - Europe

Papers in The Lancet Regional Health - Europe

Page 1 · newest first

  1. Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed populationThe Lancet Regional Health - Europe · 2026
  2. Beyond the Cath Lab: rethinking secondary prevention after STEMIThe Lancet Regional Health - Europe · 2026
  3. Long-term exposure to the general external exposome and incidence of ischemic heart disease in Europe: a meta-analysis of 14 cohortsThe Lancet Regional Health - Europe · 2026
  4. Nurse-delivered cognitive behavioural therapy for anxiety in cardiac disease versus usual care: a randomised superiority trialThe Lancet Regional Health - Europe · 2026
  5. European Medicines Agency approvals of new medicines in September and October 2026The Lancet Regional Health - Europe · 2026
  6. GLP-1 receptor agonist discontinuation and cardiovascular events and all-cause mortality in people with type 2 diabetes: a retrospective cohort studyThe Lancet Regional Health - Europe · 2026
  7. Effect of modifiable risk factors on cardiovascular and cancer mortality across European and Asian regions: a multicohort studyThe Lancet Regional Health - Europe · 2026
  8. The Scandinavian Neurotrauma Committee 2026 guidelines for initial management of minimal, mild and moderate head injuries in adults: a systematic review, meta-analysis and modified Delphi consensus studyThe Lancet Regional Health - Europe · 2026
  9. Opioid treatment patterns, trajectories, and deprescribing indicators among hospitalised adults in Switzerland, 2020–2024: a multicentre observational cohort studyThe Lancet Regional Health - Europe · 2026
  10. Community-acquired pneumonia in Europe: heterogeneity, evidence gaps, and priorities for careThe Lancet Regional Health - Europe · 2026
  11. Changes in antibiotic prophylaxis prescribing and infective endocarditis admissions in England and Scotland following changes in national guidance: a quasi-experimental longitudinal studyThe Lancet Regional Health - Europe · 2026
  12. Guideline-directed medical therapy use, persistence, and cardiovascular outcomes following ST-segment elevation myocardial infarction: a pooled analysis of three randomised trials with external registry validationThe Lancet Regional Health - Europe · 2026
  13. External validation of an artificial intelligence–based ECG algorithm for the early diagnosis of acute myocardial infarction: a prospective diagnostic cohort studyThe Lancet Regional Health - Europe · 2026
  14. 20-year trends in multiple sclerosis prevalence, incidence and age at death in Lombardy, Northern Italy: a region-wide cohort study using administrative linked dataThe Lancet Regional Health - Europe · 2026
  15. Hepatocellular carcinoma: Europe's paradox of preventable mortalityThe Lancet Regional Health - Europe · 2026
  16. Regional and national variation in donor and recipient characteristics, transplant practice, and outcomes after liver transplantation (the IMPROVEMENT collaborative): a multicentre cohort studyThe Lancet Regional Health - Europe · 2026
  17. Health-care burden of metabolic dysfunction-associated steatotic liver disease in European tertiary-care outpatient clinics (CONSTANS): a prospective multicentre cohort studyThe Lancet Regional Health - Europe · 2026
  18. Implementing antenatal vaccination in Europe: policy frameworks, barriers, and approaches for improving uptakeThe Lancet Regional Health - Europe · 2026
  19. Reforming medical device regulation in Europe: centralization, governance, and the case for an EU medical device agencyThe Lancet Regional Health - Europe · 2026
  20. Incidence of medically attended Lyme borreliosis across endemic regions of six European countries (BOLD): a prospective multicentre active surveillance studyThe Lancet Regional Health - Europe · 2026
  21. Safety of vaccines in pregnancy: from systematic exclusion to a causality assessment frameworkThe Lancet Regional Health - Europe · 2026
  22. The role of disease surveillance in maternal pertussis vaccination programmes in Europe: lessons for the futureThe Lancet Regional Health - Europe · 2026
  23. European Health Forum Gastein (EHFG) 2026The Lancet Regional Health - Europe · 2026
  24. Making health systems resilient in Europe’s new security landscapeThe Lancet Regional Health - Europe · 2026
  25. Sex- and age-specific trends in prescription medication use, 2005–2025: a nationwide repeated cross-sectional studyThe Lancet Regional Health - Europe · 2026
  26. Prevalence and mortality of chronic extracellular matrix dysregulated diseases: a nationwide register-based studyThe Lancet Regional Health - Europe · 2026
  27. The next generation of maternal vaccines: scientific advances, regulatory readiness, and strategic planning in EuropeThe Lancet Regional Health - Europe · 2026
  28. Effects of an e-health enhanced multicomponent outpatient intervention for children and adolescents with overweight or obesity in routine primary care (STARKIDS): a cluster-randomized controlled trialThe Lancet Regional Health - Europe · 2026
  29. Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European UnionThe Lancet Regional Health - Europe · 2026
  30. Life-course socioeconomic position and health in older adulthood: a causal mediation analysis in the 1958 British Birth CohortThe Lancet Regional Health - Europe · 2026
  31. Age- and sex-specific smoking trends by birth cohort in Norway, 1978–2024: an analysis of cross-sectional survey dataThe Lancet Regional Health - Europe · 2026
  32. Income-related differences in survival across disease categories in Sweden: a retrospective population-based register studyThe Lancet Regional Health - Europe · 2026
  33. Treatment restrictions after acute stroke across nine European countries and their association with 90-day mortality: a post hoc analysis of the PRECIOUS randomised controlled trialThe Lancet Regional Health - Europe · 2026
  34. Residential road traffic noise and incidence of depression in Denmark: a nationwide cohort studyThe Lancet Regional Health - Europe · 2026
  35. Socioeconomic and geographical disparities in heat-related mortality in Italy: a nationwide small-area studyThe Lancet Regional Health - Europe · 2026
  36. Dual-hormone fully closed-loop therapy versus multiple daily insulin injections or hybrid closed-loop therapy in adults with type 1 diabetes: a multicentre, open-label, randomised controlled trialThe Lancet Regional Health - Europe · 2026
  37. Biosimilar uptake policies in Europe: a cross-country mixed-methods policy analysisThe Lancet Regional Health - Europe · 2026
  38. Clinical trials on medicinal products in the EU/EEA, 2013–2025: a cross-sectional analysis of CTIS and EudraCT dataThe Lancet Regional Health - Europe · 2026
  39. Melanoma incidence in Norway, 1980–2024: a cohort studyThe Lancet Regional Health - Europe · 2026
  40. Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trialThe Lancet Regional Health - Europe · 2026
  41. Integrated care management and comprehensive geriatric assessment using a mHealth-based approach in older multimorbid patients with atrial fibrillation: the AFFIRMO cluster-randomised trialThe Lancet Regional Health - Europe · 2026
  42. Clinical practice guidelines for neonatal therapeutic hypothermia across European Society for Paediatric and Neonatal Intensive Care (ESPNIC) member countries: a multidisciplinary blind comparisonThe Lancet Regional Health - Europe · 2026
  43. Multilayered childhood adversity and mortality: a population-based cohort study of 1.2 million individualsThe Lancet Regional Health - Europe · 2026
  44. Clinical characteristics and factors contributing to transmission of congenital syphilis in England, 2015–24: a national surveillance studyThe Lancet Regional Health - Europe · 2026
  45. Trends in early-onset cancer incidence rates in the Nordic countries (2003–2022): a population-based studyThe Lancet Regional Health - Europe · 2026
  46. Drug-resistance profiles, population structure, genomic clustering, and temporal trends in drug resistance among Mycobacterium tuberculosis complex isolates in Ukraine, 2019–2023: a multicentre cohort studyThe Lancet Regional Health - Europe · 2026
  47. The burden of brain disorders in Norway: an analysis of data from the global burden of disease study 2023The Lancet Regional Health - Europe · 2026
  48. Real-world use and evaluation of a generative AI chatbot for Parkinson's disease information: a prospective observational studyThe Lancet Regional Health - Europe · 2026
  49. European Medicines Agency approvals of new medicines in July and August 2026The Lancet Regional Health - Europe · 2026
  50. Tuberculosis disease and infection screening among migrants in the Netherlands 2019–2023: a national retrospective observational studyThe Lancet Regional Health - Europe · 2026